To boost the capacity for biomedical and other high-tech research and make the state a
leader in the advancement of knowledge and a hub for high-technology industry, the New
Jersey Commission on Higher Education awarded $710,816 to NJIT to expand academic and
research programs in biomedical engineering in response to New Jerseys rapidly
growing medical device industry. The grant is one of six awards totaling $6.5 million to
six New Jersey universities.
The six universities will use the capacity-building funds to recruit renowned faculty,
purchase state-of-art equipment and launch innovative new research in biomedical and
high-tech areas with important commercial and health care applications. The proposals
approved by the commission address the needs of key New Jersey industries, such as
pharmaceuticals, biotechnology, medical devices and information technology.
"We can do things now that we couldnt do before," said David Kristol,
acting director of NJITs newly established Department of Biomedical Engineering and
director of the program for the past 18 years. "The rapid growth in the power of
computers has enabled researchers to obtain more data from living systems -- and store the
data for subsequent study -- than was previously possible. This has made it practical to
analyze and solve complex biomedical problems. The introduction of engineering into the
practice of medicine and surgery has led to a further increase in life span, but, in
addition, also has raised the quality of life."
Funds also were awarded to Princeton, Rutgers and Seton Hall universities, Stevens
Institute of Technology, and University of Medicine and Dentistry of New Jersey because
they are the states top recipients of research, doctoral or specialized (medical)
institutions according to the nationally recognized system of institutional classification
developed by the Carnegie Foundation for the Advancement of Teaching.